Company

Product

Description

Indication

Status

Akari Therapeutics plc, of London

Nomacopan

Leukotriene BLT receptor antagonist; complement C5 factor inhibitor

Thrombotic microangiopathy

FDA granted orphan status for treatment of hematopoietic stem cell transplantation-associated thrombotic microangiopathy

Glenmark Pharmaceuticals Ltd., of Mumbai, India

Pimecrolimus

Inflammatory cytokine release inhibitor

Skin conditions such as eczema

FDA approved its ANDA for generic of Bausch Health US LLC's Elidel cream

Telix Pharmaceuticals Ltd., of Melbourne, Australia

TLX-250

89Zr-radiolabeled version of girentuximab

Renal tumor

Completed a clinical trial notification submission to Japan's PMDA, allowing start of phase I/II trial designed to bridge its international ZIRCON phase III study


Notes

For more information about individual companies and/or products, see Cortellis.

 

No Comments